Tanya Lewis
Director/Board Member at DIAMEDICA THERAPEUTICS INC.
Net worth: 832 052 $ as of 2024-04-29
Tanya Lewis active positions
Companies | Position | Start | End |
---|---|---|---|
DIAMEDICA THERAPEUTICS INC. | Director/Board Member | 2023-02-28 | - |
Independent Dir/Board Member | 2023-02-28 | - |
Career history of Tanya Lewis
Former positions of Tanya Lewis
Companies | Position | Start | End |
---|---|---|---|
REPLIMUNE GROUP, INC. | Corporate Officer/Principal | 2021-05-09 | 2024-03-31 |
REPLIMUNE GROUP, INC. | Director/Board Member | 2020-11-01 | 2021-05-06 |
SYROS PHARMACEUTICALS, INC. | General Counsel | 2016-12-31 | 2018-06-30 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | General Counsel | 2015-11-29 | 2016-11-30 |
TESARO INC | General Counsel | 2010-12-31 | 2014-12-31 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | General Counsel | 2008-05-31 | 2008-05-31 |
KARYOPHARM THERAPEUTICS INC. | General Counsel | 2018-09-30 | - |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | General Counsel | 2010-07-13 | - |
░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Tanya Lewis
Massachusetts College of Pharmacy & Health Science | Graduate Degree |
Northeastern University | Undergraduate Degree |
Statistics
International
United States | 12 |
Operational
General Counsel | 7 |
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Sectoral
Health Technology | 9 |
Consumer Services | 3 |
Distribution Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
DIAMEDICA THERAPEUTICS INC. | Health Technology |
KARYOPHARM THERAPEUTICS INC. | Health Technology |
SYROS PHARMACEUTICALS, INC. | Health Technology |
REPLIMUNE GROUP, INC. | Health Technology |
Private companies | 5 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Seaside Therapeutics LLC
Seaside Therapeutics LLC Medical DistributorsDistribution Services Seaside Therapeutics LLC engages in the development of drug treatments to correct or improve the course of autism, fragile X syndrome and other neurodevelopmental disorders. Its products include STX209, STX107, and STX110. The company was founded by Randall L. Carpenter and Mark F. Bear in 2005 and is headquartered in Cambridge, MA. | Distribution Services |
- Stock Market
- Insiders
- Tanya Lewis
- Experience